Extrapolation and potential impact of IPHS deployment in Europe
|
|
- Gavin Willis
- 5 years ago
- Views:
Transcription
1 SIMPHS2 Validation Workshop Brussels, 31 Jan SIMPHS2 Validation Workshop Extrapolation and potential impact of IPHS deployment in Europe JRC IPTS IS Unit Ioannis Maghiros, Fabienne Abadie, Maria Lluch, Francisco Lupiañez, Elena Villalba, Bernarda Zamora Disclaimer: "The views expressed in this presentation are purely those of the authors and may not in any circumstances be regarded as stating an official position of the European Commission
2 Overview SIMPHS2 Validation Workshop Brussels, 31 Jan Policy objective Quantifying value of ehealth market in Europe and potential benefits with view to assessing the costseffectiveness of ehealth treatments Outline Methodology Analysis of Prevalence, mortality, and health costs Definition of Indicators linked to objectives Extrapolation and Results
3 Methodology SIMPHS2 Validation Workshop Brussels, 31 Jan Monitoring: assessing expected results Collect, analyze and complete country-level statistics on health status, resources and costs for the three main chronic diseases in the EU27 countries Translate objectives into quantitative indicators Link health status, health resources and costs to objectives and assess the level at which they can be reached through telehealth and telecare based on static ASSUMPTIONS OF IMPACT
4 Methodology SIMPHS2 Validation Workshop Brussels, 31 Jan Limitations: Impact Evaluation and Modelling Causal contribution not estimated (but assumed) Spillover effects such as economies of scale and scope not considered Dynamic feedback effects of the objectives reached to initial health status, health resources and costs not considered
5 Methodology SIMPHS2 Validation Workshop Brussels, 31 Jan Indicators linked to objectives Value of ehealth potential market: as the product of prevalence (number of people suffering a disease) by the assumed levels of ehealth deployment and of monitoring costs of the ITC components Savings in hospitalization: as the product of total hospital bed days used by its costs, and by the assumed parameters about ehealth deployment and about impact on reduced hospitalization Value of reduced mortality: as the product of number of deaths caused by disease by the assumed parameters about ehealth deployment and about impact on reduced mortality Break-even indicator: costs per ehealth monitored day such that the Value of ehealth potential market equals the Savings in hospitalization
6 Health Status: Chronic Diseases SIMPHS2 Validation Workshop Brussels, 31 Jan Are there systematically healthier countries? Life Expectancy Prevalence 3-Chronic Life Expectancy and Morbidity in EU27 IT DE EL BU LV PT SE EE BEAT HU FR FI LT SI ES UK RO CZ NL MT PL CY SK IE GDP per capita - EUR 2010 Life Expectancy PL LT EL BU HU PT RO ES CZ CY IT EE LV SKMTSI UK DE AT FR FINLSE BEIE DK Percentage 65 and older GDP per capita - EUR 2010 Prevalence Source:Authors'elaboration from different databases. 3-Chronic: CHF, COPD and Diabetes. DK Mortality LU LU Percentage 65 and older Mortality 3-Chronic EU27 Life exp.: 79.4 years EU27 GDPpc: 24,442 EU27 %65 and older: EU27 Prevalence 3-chronic: 14.24% EU27 Mortality 3-chronic: 0.125% Pearson/Spearman Rank Corr. Prevalence ~ Life -.08/-.03 expectancy Prevalence ~ Mortality.42*/.55* 3-chronic Prevalence ~GDPpc -.22/-.26* Life expect. ~ GDPpc.65*/.71* Mortality ~ GDPpc -.55*/-.69* Mortality 3-chronic ~ Life expectancy Prevalence ~ % 65 and older Mortality 3-chronic ~ % 65 and older -.64*/-.52*.51*/.49*.13/.23*
7 Health Status: Chronic Diseases SIMPHS2 Validation Workshop Brussels, 31 Jan Prevalence: Data availability and imputations Diabetes: Diabetes Atlas 4 th Edition, 2010, national series (measured over age group) CHF: No international statistics in prevalence of coronary diseases Literature estimates range of 1% to 3% for CHF prevalence Frost&Sullivan 2010 (F&S) collects data on CVD prevalence for 12 of the EU27 countries - Assumption: the variability of CHF prevalence is highly correlated to the percentage of hospital discharges diagnosed as Heart Failure (HF) over total hospital discharges. - Data on hospital discharges in HF available from HMDB WHO/Europe and Eurostat - Average EU27 % hospital discharges HF = 1.96%. - Correlation % hospital discharges HF and CVD prevalence = 33%. COPD: F&S collects prevalence statistics for 18 countries. The data for the remaining countries have been completed first from Health For All Database WHO/Europe (HFA-DB) and by taking the percentage of hospital discharges in COPD for the cases of Cyprus, Estonia and Slovenia. The correlation coefficient between the series taken from F&S and the alternative series reach a 36%.
8 Health Status: Chronic Diseases SIMPHS2 Validation Workshop Brussels, 31 Jan Prevalence: Data availability and imputations Finland Sweden Denmark Portugal Hungary Italy Spain Cyprus Malta Latvia Ireland UK Prevalence of Chronic Diseases Cluster A Cluster B Germany Austria France Netherlands Poland Greece Lithuania Bulgaria Romania Czech Rep. Estonia Belgium Slovenia Luxembourg Slovakia Source:Authors'elaboration from different databases. CHF prevalence is assumed equal to percentage of hospital discharges in Heart Failure. COPD prevalence combines Frost & Sullivan and WHO/Europe statistics. Diabetes prevalence is taken from Diabetes Atlas 4th Edition on national series. Cluster D Cluster C EU27: CHF:1.96% COPD :3.32% Diabetes:8.96% CHF COPD Diabetes Data on prevalence in scientific literature: CHF: 1-3% COPD: 4-10% Diabetes: 8.9%
9 Health Status: Chronic Diseases SIMPHS2 Validation Workshop Brussels, 31 Jan Prevalence: Data availability and imputations Percentage of Hospital Discharges Cluster A Cluster D Sweden Germany Austria Finland France Denmark Netherlands Cluster B Cluster C Rank correlation hospital discharges and prevalence: - 3 chronic: 0.48* - diabetes: 0.22* - COPD: 0.15* Spain Hungary Malta Italy Ireland UK Cyprus Latvia Portugal Source:Authors'elaboration from different databases. Greece Bulgaria Romania Poland Lithuania Belgium Estonia Czech Rep. Luxembourg Slovakia Slovenia EU27: CHF:1.96 COPD:1.40 Diabetes: CHF COPD Diabetes
10 Health Status: Chronic Diseases SIMPHS2 Validation Workshop Brussels, 31 Jan Mortality: Data availability and imputations Annual mortality rates are reported for Diabetes. For CHF and COPD, mortality data correspond to the higher classification of diseases: CVD and All Respiratory Diseases, respectively. Assumption: to obtain mortality caused by CHF and COPD a fraction equal to the part of hospital discharges in CHF over CVD, and to the part of hospital discharges in COPD over all respiratory diseases, is multiplied to the reported mortality caused by CVD and all respiratory diseases, respectively. WHO Department of Measurement and Health Information, reports number of deaths caused by COPD.
11 Health Status: Chronic Diseases SIMPHS2 Validation Workshop Brussels, 31 Jan Mortality: Data availability and imputations Sweden Chronic Diseases Mortality Cluster A Germany (Cluster D EU27 Total deaths caused by: Finland Denmark Hungary Malta Italy Spain Portugal Latvia UK Cyprus Ireland Cluster B Austria France Netherlands Bulgaria Romania Greece Lithuania Poland Estonia Czech Rep. Slovakia Belgium Slovenia Luxembourg Cluster C EU27: CHF:.055% COPD:.014% Diabetes:.055% CHF: 277,161 - COPD: 71,456 - Diabetes: 277,896 Total deaths of 65+ population: 3,884,592 CHF COPD Diabetes Source:Authors'elaboration from different databases. CHF mortality is assumed equal to a fraction of CVD mortality, the fraction being %hospital discharges in HF over CVD COPD mortality is assumed equal to a fraction of respiratory diseases mortality, the fraction being %hospital discharges COPD over respiratory diseases. Diabetes mortality is taken from Diabetes Atlas 4th Edition.
12 Healthcare expenditures SIMPHS2 Validation Workshop Brussels, 31 Jan CHF per in-patient costs are assumed equal to CVD per in-patient costs, with total-inpatient costs taken from the European Cardiovascular Disease Statistics 2008 (British Heart Foundation). COPD per-inpatient costs are assumed equal to average for all diseases. Diabetes in-patient costs are assumed a 35% of the costs reported by the Diabetes Atlas, being 35% the percentage of in-patient expenditures over health expenditures at EU27 level. Number of in-patients and number of bed days data from HMDB WHO/Europe and Eurostat. Series of hospital costs per in-patient Series of costs per hospital bed day
13 Healthcare expenditures SIMPHS2 Validation Workshop Brussels, 31 Jan Assumption: COPD average costs per hospital bed day equal average costs per hospital bed day for all diseases, estimated at 649 Figure: COPD, the in-patient costs are estimated at 5,400 per in-patient ( 602 per hospital bed day) for all EU27 countries. Mapel D.W. (2005) Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respiratory Medicine, 99,
14 Healthcare expenditures SIMPHS2 Validation Workshop Brussels, 31 Jan Euros Average Costs per Hospital Patient Cluster A Cluster D Euros for Diabetes EU27 Healthcare expenditure: 1,179,625 Mill EUR Healthcare Expenditure per capita: 2,079 EUR In-patient expenditure: 432,900 Mill EUR Euros DK FI Cluster B SE AT BE FR EU27: CHF: 5,049 Diabetes: 42,677 All Diseases: 5,112 BU CZ EE EL Cluster C LT LU DE PL RO SK NL SI Euros for Diabetes In-patient expenditure per in-patient: 5,112 CVD expenditure: 109,689 (59,102 in-patient) Mill EUR As % of healthcare exp: 9.3 CY HU IE IT LV MT PT ES UK CHF All Diseases Diabetes Source:Authors'elaboration from different databases. CHF costs are assumed equal to CVD costs Diabetes costs are calculated by assuming that in-patient costs are a 35% of total diabetes costs. Diabetes expenditure: 112,353 Mill EUR As % healthcare exp: 9.5
15 Healthcare expenditures SIMPHS2 Validation Workshop Brussels, 31 Jan Euros Average Costs per Hospital Bed Day Cluster A Cluster D Diabetes Euros CY HU IE IT LV MT PT ES UK DK FI SE AT FR DE NL Cluster B BE BU CZ EE EL Cluster C LT EU27: CHF: 564 Diabetes: 4,057 All Diseases: 649 LU PL RO SK SI Diabetes CHF All Diseases Diabetes Source:Authors'elaboration from different databases. CHF costs per bed day are assumed equal to CVD costs COPD costs per bed day are taken equal to costs per bed day for All Diseases (US data analysis by Mapel, 2005 estimates at 602 Euros approx.). Diabetes costs are calculated by assuming that in-patient costs are a 35% of total diabetes costs.
16 Translate Objectives into Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan Objectives of the extrapolation exercise: Potential market: costs of the ITC ehealth component Impact: benefits translated to: - reduction of healthcare costs, in particular hospitalization costs - improvement of quality of life, in particular delaying mortality one year
17 Link input data to Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan
18 Link input data to Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan Assumptions on ehealth deployment and its costs: Telehealth - deployment level of 20% - cost per monitored patient per day at 4 which corresponds to the tender costs of a telehealth project in Lombardy (Abadie, F. et al., 2011) Telecare - deployment level of 16% over the 65 and older population - cost of 0.5 per patient per day. It has been found that the monitoring costs of 1st generation telecare ranges between 10 and 30 Euros per month (DG INFSO: ICT & Ageing: European Study on Users, Markets and Technologies, 2010)
19 Link input data into Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan
20 Link input data to Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan Impact Assumptions on reduced hospitalization: - Σ is defined as a 25% reduction in bed days for patients treated by telehealth, according to a Care Coordination/Home Telehealth" program introduced by the Veterans Health Administration in the US (See Abadie, F. et al. 2011).
21 Link input data to Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan
22 Link input data to Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan Impact Assumptions on reduced mortality: The assumed monetary value of an extra year of life (Ω) is 30,000 Euros. The parameter of reduced deaths Μ : - 35% of the number of deaths of telehealth monitored patients - 20% of the number of deaths of telecare monitored patients. - This benchmark for reduced death at 35% is higher than other benchmarks found in the literature at 20%, but lower than the one estimated from the Whole System Demonstrator programme in UK which reaches a 45% (Headline Findings Department of Health. UK).
23 Link input data into Indicators SIMPHS2 Validation Workshop Brussels, 31 Jan
24 Expected Results: Potential Market SIMPHS2 Validation Workshop Brussels, 31 Jan Projections at EU19 level obtained in SIMPHS1 (Abadie et al. 2011)
25 Expected Results: Potential Market SIMPHS2 Validation Workshop Brussels, 31 Jan Mill. Euros ,000 4,000 6,000 8,000 Telehealth and Telecare Market Value EU27(Billion EUR) CHF:2.843 COPD:4.860 Diabetes:9.612 Telecare:2.543 Cluster D Cluster B Cluster C Cluster A CHF COPD Diabetes Telecare Source:Authors'elaboration from different databases. Assumed deployment level: 20% for telehealth and 16% for telecare. Assumed costs per monitored patient per day: 4 for telehealth and 0.5 for telecare. Cluster A: DK,SE,FI Cluster B: CY,HU,IE,IT,LV,MT,PT,ES,UK Cluster C: BE,BU,CZ,EE,EL,LI,LU,PO,RO,SK,SI Cluster D: AT,DE,FR,NL
26 Expected Results: Savings in Hospitalization SIMPHS2 Validation Workshop Brussels, 31 Jan Mill. Euros ,000 1,500 Savings from Reduced Hospitalization EU27(Billion EUR) CHF:0.438 COPD:0.356 Diabetes:1,966 Cluster D Cluster B Cluster C Cluster A CHF COPD Diabetes Source:Authors'elaboration from different databases. Assumed telehealth deployment level: 20 percent. Impact on reduced hospitalization assumed at 25 percent of bed days Cluster A: DK,SE,FI Cluster B: CY,HU,IE,IT,LV,MT,PT,ES,UK Cluster C: BE,BU,CZ,EE,EL,LI,LU,PO,RO,SK,SI Cluster D: AT,DE,FR,NL
27 Expected Results: Value of Reduced Mortality SIMPHS2 Validation Workshop Brussels, 31 Jan Mill. Euros ,000 1,500 2,000 Value of Reduced Mortality EU27 (Billion EUR) CHF:0.582 COPD:0.150 Diabetes:0.584 Telecare:3.729 Cluster D Cluster B Cluster C Cluster A CHF COPD Diabetes Telecare Source:Authors'elaboration from different databases. Assumed deployment level: 20% for telehealth and 16% for telecare. Impact on reduced mortality: 35 percent for telehealth over chronic patients and 20% for telecare over 65 and older population Cluster A: DK,SE,FI Cluster B: CY,HU,IE,IT,LV,MT,PT,ES,UK Cluster C: BE,BU,CZ,EE,EL,LI,LU,PO,RO,SK,SI Cluster D: AT,DE,FR,NL
28 Expected results: cost-benefit SIMPHS2 Validation Workshop Brussels, 31 Jan Break-even: COPD Telehealth Market Break-even: Chronic Hearth Failure Telehealth Market UK NL DE LU SE FR BE DK IE PT FI AT IT EL SI CZ ES PL SK LT LV EE MT CY HU RO BU Euros per patient-day Break-even on savings hospitalization Value reduced mortality Euros per patient-day MT LU BE IE NL EL DK AT ES UK SI IT FR CY SE DE FI PT RO EE BU SK CZ HU LT LV PL Break-even on savings hospitalization Value reduced mortality Break-even: Diabetes Telehealth Market LU DK NL SE AT FR BE DE FI UK IT ES EL CY IE SI PT MT SK CZ HU PL EE LT LV BU RO Euros per patient-day Break-even on savings hospitalization Value reduced mortality
29 Expected Results: cost-benefit SIMPHS2 Validation Workshop Brussels, 31 Jan Break-even: Total Telehealth Market LU UK NL DK BE MT DE SE FR AT IE IT FI EL ES PT SI CY CZ SK EE PL HU LT LV RO BU Euros per patient-day Break-even for CHF Break-even for COPD Break-even for Diabetes
30 Toolkit extrapolation framework SIMPHS2 Validation Workshop Brussels, 31 Jan Austria Belgium Bulgaria Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Please, select countries/regions Latvia Lithuania Luxembourg Malta Netherlands Poland Portugal Romania Slovakia Slovenia Spain EU27 Cluster A Cluster D Cluster B Telehealth Correlation deployment level Deployment level 20 0 With: (1 to 100) Overall ehealth readiness index 1 Cost per patient-day 4 (Euros) Cluster C Reduction Mortality 35 (1 to 100) A: DK, FI, SE D: AT,DE,FR,NL Reduction hospital use 25 B: CY,HU,IE,IT,LV,MT,PT,ES,UK (1 to 100) C: BE,BU,CZ,EE,EL,LI,LU,PO,RO, SK,SI LOAD Please, input parameters ICT healthcare expenditure index Seeking health information in internet index Hospital ehealth deployment index Chronic Illness COPD Telecare Correlation deployment level Deployment level 16 0 With: (1 to 100) Overall ehealth readiness index ICT healthcare expenditure index Seeking health information in internet index Cost per patient-day Hospital ehealth deployment index (Euros) CHF Diabetes Hungary Ireland Sweden United Kingdom Reduction Mortality 20 (1 to 100) Italy
31 Next step: Modelling Impact SIMPHS2 Validation Workshop Brussels, 31 Jan We can do better. Can we have a Break-even depending on the ehealth Deployment level? - Different growth rate of monitored total patients than monitored hospitalized patients - Adding an effect of deployment level on average length of stay in hospitals Break-even increasing with deployment level? Yes, if the effect on reduced hospitalization increases at higher rate than the monitored patients. Can we estimate feedback effects of deployment level on prevalence and mortality rates?
32 And finally. SIMPHS2 Validation Workshop Brussels, 31 Jan Discussion Any post-workshop issues:
Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective
Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Prof. Ing. Juraj Nemec, CSc. Masaryk University, Czech Republic, Size of government
More informationTransmission, processing and publication of HBS 2015 data
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-4: Income and living conditions; Quality of life Doc. LC-ILC/194/17/EN estat.f.4 (2017) WORKING GROUP ON INCOME AND LIVING CONDITIONS
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationTrends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
More informationNew trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
More informationFresh fruit and vegetable production, trade, supply & consumption monitor in the EU-27 (covering ) With the support of:
Fresh fruit and vegetable production, trade, supply & consumption monitor in the EU-27 (covering 2005-2010) With the support of: Freshfel Fruit and Vegetable Production, Trade, Supply & Consumption Monitor
More information'SECTION B EU PARTY. The following abbreviations are used:
'SECTION B EU PARTY The following abbreviations are used: AT Austria BE Belgium BG Bulgaria CY Cyprus CZ Czech Republic DE Germany DK Denmark ES Spain EE Estonia EU European Union, including all its Member
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationPalliative nursing care of children and young people across Europe
Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)
More informationA new scale to measure tobacco control activity in a country: data tables and questionnaire
A new scale to measure tobacco control activity in a country: data tables and questionnaire 1 Appendix 1: Smoke free public places - score on 1 July 2005 in 30 European countries Country Bars and restaurants
More informationFieldwork: February March 2010 Publication: October 2010
Special Eurobarometer 345 European Commission Mental Health Part 1: Report Fieldwork: February March 2010 Publication: October 2010 Special Eurobarometer 345 / Wave 73.2 TNS Opinion & Social This survey
More informationEUROPEAN CITIZENS DIGITAL HEALTH LITERACY
Flash Eurobarometer 404 EUROPEAN CITIZENS DIGITAL HEALTH LITERACY SUMMARY Fieldwork: September 2014 Publication: November 2014 This survey has been requested by the European Commission, Directorate-General
More informationSmokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
More informationReview of Member State approaches to the Macrophyte and Phytobenthos Biological Quality Element in lakes
Review of Member State approaches to the Macrophyte and Phytobenthos Biological Quality Element in lakes Report to ECOSTAT Martyn Kelly (Bowburn Consultancy, UK) Sebastian Birk (University of Duisburg-Essen,
More informationEU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017
EU Market Situation for Poultry Committee for the Common Organisation of the Agricultural Markets 2 April 217 -9.% -11.% -5.% -.1% -.7% -2.2% 3.% 1.7% 1.2%.8%.6%.%.%.% 7.9% 7.% 6.4% 6.2% 6.% 5.5% 5.3%
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationYoung people and drugs. Analytical report
Flash Eurobarometer European Commission Young people and drugs among 15-24 year-olds Analytical report Fieldwork: May 2008 Report: May 2008 Flash Eurobarometer 233 The Gallup Organization This survey was
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL ON FOOD INGREDIENTS TREATED WITH IONISING RADIATION FOR THE YEAR 2012
EUROPEAN COMMISSION Brussels, 4.2.2014 COM(2014) 52 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL ON FOOD INGREDIENTS TREATED WITH IONISING RADIATION FOR THE YEAR 2012 EN
More informationMeeting report, September 2005
European Medicines Agency Post-authorisation Evaluation of Medicines for Human Use London, 24 October 2005 Doc. Ref. EMEA//322553/2005 COMMITTEE ON HERBAL MEDICINAL PRODUCTS () Meeting report, 19-20 September
More information31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million
31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million cancer cases Adult patients (age 15+) 45 major cancer sites
More informationWCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
More informationWCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
More informationWCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
More informationCross Border Genetic Testing for Rare Diseases
Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic
More informationReport. Survey conducted by TNS political & social
Food waste and date marking Survey conducted by TNS political & social This document does not represent the point of view of the European Commission. The interpretations and opinions contained in it are
More informationManuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal
Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging
More informationUpdate on EEA s near real time air quality data exchange
Update on EEA s near real time air quality data exchange Jaume Targa (EEA ETC/ACC) Acknowledgement Thanks to all nrt data providers Currently there are 71 providers Latvian Environment, Geology and Name
More informationProposal for the future operationalisation of GALI in social surveys
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-5: Education, health and social protection DOC 05-PH-03 Proposal for the future operationalisation of GALI in social surveys Meeting
More informationEstimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries
1 Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries Introduction Mariachiara Di Cesare and Mike Murphy Department of Social Policy, London
More informationEIIW Competitiveness Report on the EU Market
EIIW Competitiveness Report on the EU Market Jens K. Perret Wuppertal, January 215 Preliminary European Institute for International Economic Relations at the University of Wuppertal, Rainer-Gruenter-Str.
More informationGlobal Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015
Page 1 5/18/2015 An Analysis of Global Trade in Lightweight paper, coated with inorganic substances, used for writing etc., of which more than 10% by weight of total fibre content consists of fibres obtained
More informationUK bowel cancer care outcomes: A comparison with Europe
UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The
More informationOverview of European Consumption Databases
FEDERAL INSTITUTE FOR RISK ASSESSMENT Overview of European Consumption Databases Katrin Büsch Workshop Food Consumption Data and Dietary Exposure in the European Union, 15-16 May 2008, Berlin Introduction
More informationThe cancer burden in the European Union and the European Region: the current situation and a way forward
The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers
More informationCurrent levels and recent trends in health inequalities in the EU: Updates from the EU Report
Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Anne Scott London Health Observatory Expert Working Group on Social Determinants and Health Inequalities Luxembourg,
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationSpecial Eurobarometer 445. Report. Antimicrobial Resistance
Survey requested by the European Commission, Directorate-General for Health and Food Safety and co-ordinated by the Directorate-General for Communication This document does not represent the point of view
More informationEuropean Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
More informationScreening for Cervical Cancer in Europe
Asturias, 23 October, 2011 Asturias, 23 October Screening for Cervical Cancer in Europe M. Arbyn Unit Cancer Epidemiology, IPH, Brussels, Belgium Rue Juliette Wytsmanstraat 14 1050 Brussels Belgium T +32
More informationEuropean Collaboration on Dementia. Luxembourg, 13 December 2006
European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,
More informationSPECIAL EUROBAROMETER 332. Fieldwork: October 2009 Publication: May 2010
SPECIAL EUROBAROMETER 332 Special Eurobarometer 332 Tobacco European Commission Tobacco Fieldwork: October 2009 Publication: May 2010 Special Eurobarometer 332 / Wave TNS Opinion & Social This survey was
More informationWhere we stand in EFORT
Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section
More informationMedical Physicists Improving treatments, saving lives
Medical Physicists Improving treatments, saving lives EFOMP presentation to the ICARO- 2 Conference The Role of professional societies and international organizations Dr. Stefano Gianolini Council Delegate
More informationAlcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe
Alcohol in Europe and Brief Intervention Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Global risk factors ranked by attributable burden of disease 2010 (GBD, Lancet,
More informationCost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,
Cost of Disorders of the Brain in Europe 2010 Gustavsson et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsych. (2011) 21, 718-779 Steering Committee Prof Jes Olesen 1 Prof Bengt Jönsson
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationLEBANON. WCPT COUNTRY PROFILE December 2018
LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000
More informationAnnual epidemiological report 2014 food- and waterborne diseases and zoonoses
Annual epidemiological report 2014 food- and waterborne diseases and zoonoses SURVEILLANCE REPORT Salmonellosis Salmonellosis is the second most commonly reported gastrointestinal infection and an important
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
More informationPARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information
PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria
More informationERGP (12) 31 report on complaints handling ERGP REPORT ON THE ASSESSMENT OF COMPLAINT HANDLING PROCEDURES AND CONSUMER PROTECTION
ERGP REPORT ON THE ASSESSMENT OF COMPLAINT HANDLING PROCEDURES AND CONSUMER PROTECTION 1 Content Page 0. Executive Summary 7 1. Background 11 2. Objectives 12 3. Methodology 13 4. Legal framework on complaint
More informationDENMARK. WCPT COUNTRY PROFILE December 2018
DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000
More informationTrichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
Annual Epidemiological Report for 2015 Trichinellosis Key facts In 2015, a total of 156 confirmed cases of trichinellosis was reported from 29 EU/EEA countries. The overall notification rate was 0.03 cases
More informationANNUAL REPORT on surveillance for avian influenza in poultry in the EU in 2009
EUROPEAN COMMISSION ANNUAL REPORT on surveillance for avian influenza in poultry in the EU in 2009 Prepared by the European Union Reference Laboratory for Avian Influenza Neither the European Commission
More informationGERMANY. WCPT COUNTRY PROFILE December 2018
GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000
More informationOutcome of proficiency test on EIA serology
Outcome of proficiency test on EIA serology Anses Dozulé Laboratory for equine diseases VIPARE unit Delphine Gaudaire EIA PT GENERAL INFORMATION AIM OF THE PT Detect EIA antibodies: using Agar Gel Immuno-Diffusion
More informationEngagement in language assessment / Regions of Europe
Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears
More informationSpreading Excellence and Widening Participation
Spreading Excellence and Widening Participation Dr G Ambroziewicz Ankara, 27/02/2017 Research and Background Disparities in research and innovation performance: barrier to competitiveness, growth and jobs
More informationWorkers health surveillance: implementation of the Directive 89/391/EEC in Europe
Occupational Medicine 2017;67:574578 Advance Access publication 19 August 2017 doi:10.1093/occmed/kqx113 Workers health surveillance: implementation of the Directive 89/391/EEC in Europe C. Colosio 1,
More informationRheumatoid Arthritis Disease Burden and Access to Treatment
Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers
More informationChemical Occurrence. Exposure Assessment. Food Consumption
Food consumption database and EU Menu proposal Stefan Fabiansson Data Collection and Exposure Unit EU Menu project What s on the menu in Europe? A harmonised pan-european food consumption survey Building
More informationYouth attitudes on drugs. Analytical report
Flash Eurobarometer 33 The Gallup Organization? Flash Eurobarometer European Commission Youth attitudes on drugs Analytical report Fieldwork: May 211 Report: June 211 This survey was requested by Directorate-General
More informationEuropean Community Pharmacy: a reference in Public Health
European Community Pharmacy: a reference in Public Health Ilaria Passarani PGEU Secretary General 4 October 2018, Burgos, Spain Pharmaceutical Group of European Union Members: Professional Bodies & Pharmacists
More informationBiology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium
More informationYersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Yersiniosis Key facts In 2015, 26 countries reported 7 279 confirmed yersiniosis cases in the EU/EEA. The overall notification rate was 2.0 cases
More informationPrimary and secondary prevention of sudden cardiac death in emerging economies
Primary and secondary prevention of sudden cardiac death in emerging economies Béla Merkely MD, PhD, DSc, FESC Heart Center Semmelweis University Budapest Common risk factors for sudden cardiac death Increasing
More informationFieldwork: October 2009 Publication: February 2010
SPECIAL EUROBAROMETER 329 Special Eurobarometer 330 Health Determinants Report Oral health Fieldwork: October 2009 Publication: February 2010 Special Eurobarometer 330 / Wave TNS Opinion & Social This
More informationAlcohol Prevention Day
Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in
More informationEmerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018
Emerging Risks Mapping of Activities in Member States 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018 BACKGROUND 67 th Advisory Forum Meeting, Utrecht, The Netherlands, 6 February
More informationAttitudes of Europeans towards tobacco
Special Eurobarometer European Commission Attitudes of Europeans towards tobacco Fieldwork September December 2005 Publication January 2006 Special Eurobarometer 239 / Waves 64.1 64.3 TNS Opinion & Social
More informationNational level ICD 9-3 digit Nuts II european shortlist Croatia 1999/2000 From WHO ICD-10, 4 digit. 1999/2000 From WHO ICD-10, 4 digit
Gleb Denissov Reference Period Transmission to Eurostat Data Albania 1999/2000 From WHO ICD-9, 3 digit Bulgaria 1999/2000 National level from WHO Nuts II level by e-mail National level ICD 9-3 digit Nuts
More informationAtherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke
«L Europe de la santé au service des patients» 13-14 October 2008 - Institut Pasteur Paris Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke Simona Giampaoli National Centre of
More informationDrinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results
Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini, S. Martire Istituto Superiore
More informationTHE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
More informationFemale genital mutilation: estimating girls at risk. Jurgita Peciuriene
Female genital mutilation: estimating girls at risk Jurgita Peciuriene EU framework Resolution 2012 on ending FGM Resolution 2014 on the Commission communication Towards the elimination of FGM Web-platform
More informationTramadol-related deaths
Tramadol-related deaths 216 Survey overview European joint DRD expert meeting Lisbon, 29-3 September 216 Isabelle Giraudon, Federica Mathis, Klaudia Palczak Paralel workshop Opioids, medicines and focus
More informationThe Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert
Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.
More informationWhere do EU Contries set the limit for low risk drinking.
Where do EU Contries set the limit for low risk drinking. Results from the EU RARHA survey E. Scafato,L. Galluzzo, S. Ghirini, C. Gandin Istituto Superiore di Sanità, Italy WP5: Outline of the work (tasks)
More informationFeedback on the first Widening Calls
Feedback on the first Widening Calls Some facts figures Dimitri Corpakis Head of Unit Spreading Excellence Widening Participation DG Research, European Commission Brussels, CPU Clora, 18/3/15 Criteria
More informationUnderage drinking in Europe
Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project
More informationProject Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
More informationNutrient profiles for foods bearing claims
Nutrient profiles for foods bearing claims Fields marked with * are mandatory. Background Regulation (EC) 1924/2006 (Nutrition and Health Claims NHC Regulation) establishes EU rules on nutrition and health
More informationreal-time AQ data 2007 and plans for 2008
real-time AQ data 2007 and plans for 2008 Tim Haigh - project manager Information Resources http://www.eea.europa.eu/maps/ozone/map/ Where is all the data coming from? EEA NRT Database 4000 2000 700 EEA
More informationTEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée
Teddy Network of Excellence Annagrazia ALTAVILLA TEDDY Task-force in Europe for Drug Development for the Young Ph.D. Sciences Ethics LL.M. Health Law Associated Senior Lecturer Université de la MéditerranM
More informationScreening programmes for Hepatitis B/C in Europe
Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis
More informationThe Risk of Alcohol in Europe. Bridging the Gap June 2004
The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT. Accompanying document to the
EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 30.6.2009 SEC(2009) 894 Part 1 COMMISSION STAFF WORKING DOCUMENT Accompanying document to the Proposal for a COUNCIL RECOMMENDATION on smoke-free
More informationHIV/AIDS Joint Action HA-REACT
HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission
More informationALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY
ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY JACEK MOSKALEWICZ INSTITUTE OF PSCHIATRY AND NEUROLOGY WARSAW, POLAND THIRD EUROPEAN CONFERENCE ON ALCOHOL AND LAW ENFORCEMENT,
More informationInjecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration
Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Alexander Grabenhofer-Eggerth TDI expert meeting - Lisbon,
More informationMen & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013
Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the
More informationEUROBAROMETER SPECIAL 332. Fieldwork: October 2009 Publication: May 2010
Special Eurobarometer 332 European Commission Tobacco Summary Fieldwork: October 2009 Publication: May 2010 Special Eurobarometer 332 / Wave 72.3 TNS Opinion & Social This survey was requested by the Directorate-General
More information